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the gradient on the basis of the degree of in vivo antibody 
coating and aggregation. 
The authors also concentrated enough core particles 
to analyze the HCV native nucleocapsid protein on 
SDS-PAGE and ELISA. The molecular weight of the 
core protein was determined to be approximately 26,000 
Da (p26). The native core antigen polypeptide occurring 
in the circulation of an infected host appeared signifi- 
cantly larger than that predicted from residues 1 
through 191 of the putative HCV core gene translational 
product. This could be due to a different cleavage site in  
vzvo than that predicted or to a posttranslational 
modification. To address this disparity and to speculate 
on its biological significance will require the isolation of 
larger quantities of native particles and their associated 
proteins. 
This study provides our first confident glimpse at the 
long-sought particle associated with NANB/HCV in- 
fection. Although the quality of the EM picture is not 
optimal and although evidence for the positive identifi- 
cation of the HCV virion is only partial, considering the 
low concentration of viral particles in the circulation, 
this study is a monumental achievement. With this 
breakthrough in hand, progress toward final character- 
ization of the HCV virion should be rapid. 
HARVEY J. ALTER, M.D. 
JAMES W.-K. SHIH, PH.D. 
National Institutes of  Health 
Department of Transfusion Medicine 
Bethesda, Maryland 20892 
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CAN THE LIVER BE INDUCED TO SAY NO? 
Hortelano S, Genaro AM, Bosca L. Phorbol esters induce 
nitric oxide synthase activity in rat hepatocytes: antag- 
onism with the induction elicited by lipopolysaccharide. 
J Biol Chem 1992;267:24937-24940. 
ABSTRACT 
The incubation of primary cultures of rat hepato- 
cytes with lipopolysaccharide (LPS) or biologically 
active phorbol esters promotes the release of nitric 
oxide to the incubation medium. This process is the 
result of the induction of the Ca2+- and calmodulin- 
independent form of nitric oxide synthase. Both the 
release of nitric oxide to the incubation medium and 
the expression of nitric oxide synthase activity ex- 
hibited a lag period of about 45-60 min after cell 
stimulation. Exposure of hepatocytes to both stimuli 
produced an antagonistic effect on nitric oxide release, 
with a half-maximal inhibition obtained with 14 nM 
phorbol 12,13-dibutyrate at saturating concentration 
of LPS. Incubation of cells with a-phorbol 12,13- 
didecanoate failed to counteract the effect of LPS or to 
induce nitric oxide synthase, suggesting that acti- 
vation of protein kinase C was involved in this process. 
COMMENTS 
Nitric oxide (NO) has been implicated in a variety of 
physiological processes including smooth muscle relax- 
ation, immune regulation, penile erection, platelet inhi- 
bition and neurotransmission (1). The discovery of the 
role of NO in these processes has been a rapidly evolving 
story. Prior to reports in 1987 that NO was synonymous 
with endothelium-derived relaxing factor, the concept 
that a gas could act as a second messenger was not well 
accepted (2). The key to establishing the significance of 
NO in biological systems was the demonstration that the 
enzymatic machinery for its generation existed in a 
variety of tissues. NO is produced by nitric oxide 
synthase (NOS). Two types of NOS have been identified 
to date: they are “constitutive” and “inducible” forms 
(3, 4). Both types utilize L-arginine and NADPH as 
substrates and are located in the soluble fraction of the 
cell. The constitutive form is Ca2+ and calmodulin 
dependent, whereas the inducible form does not require 
Ca2+ or calmodulin for its function but requires tet- 
rahydrobiopterin as a cofactor. Interferon-y, cytokines 
and bacterial lipopolysaccharide (LPS) activate the 
inducible form of NOS (5 ,  6). The two types of NOS 
exhibit differential sensitivity to the inhibitory actions 
of L-arginine analogs: NG-monomethyl-L-arginine is 
significantly more potent than NG-nitro-L-arginine in 
inhibiting the inducible form of NOS, whereas the 
opposite is true for the constitutive form of the enzyme 
(1). 
In a variety of tissues NO activates soluble guanylate 
cyclase (7). Elevation of cyclic GMP is associated with 
smooth muscle relaxation in the cardiovascular system 
and gastrointestinal tract (8, 9). 
Hepatocytes demonstrate specific responses to NO, 
including inhibition of mitochondria1 respiration, 
control of glycogenolysis and inhibition of protein syn- 
thesis in cultures of Kupffer and hepatocyte cells 
(10-12). Kupffer cells demonstrate some constitutive 
NOS activity, but none is detectable in hepatocytes 
studied with immunological techniques (13). 
An important second messenger system in hepato- 
cytes involves phosphoinositide turnover resulting in 
generation of inositol-1,4,5-triphosphate (IP,) and di- 
acylglycerol (DAG). IP, triggers mobilization of an 
intracellular pool of calcium, and DAG activates protein 
kinase C (PKC). Phorbol esters mimic the action of DAG 
to activate PKC. Activation of PKC is associated with 
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inhibition of agonist-mediated stimulation of cytosolic 
calcium oscillations in hepatocytes (14). 
Hortelano et al. demonstrated that phorbol esters and 
LPS promote expression of the inducible form of NOS in 
cultured hepatocytes. The constitutive form of NOS was 
not detectable in the cultured hepatocytes. Exposure of 
hepatocytes to both agents had an inhibitory effect on 
NO release. This is an interesting series of experiments 
that set the stage for future studies. Much of the work 
on NO has focused on the role of the constitutive form 
of NOS because it represents an ideal system for 
generating an autocrinelparacrine messenger - (a) NO 
has a short half-life, degrading within 5 to 10 sec to 
nitrite and nitrate; (b) it is membrane permeant and (c) 
it is a potent stimulator of cyclic GMP by way of 
activation of the soluble form of guanylate cyclase. 
A fundamental issue in the inducible form of NOS is 
clarification of its physiological role. The authors 
suggest that the inducible form of NOS participates in 
the liver’s response to bacteremia and sepsis on the basis 
of reports that LPS and various cytokines induce this 
form of the enzyme (5, 6). 
It will be interesting to examine the signal-trans- 
duction pathways that link LPS, cytokines and inter- 
feron-? to activation of the inducible form of NOS. Do 
these agents stimulate the release of NO by directly 
activating the inducible form of NOS or, perhaps, 
indirectly by stimulating PKC, which in turn activates 
NOS? If these agents act by means of PKC, then their 
effect on NOS activity and NO release should be 
antagonized by inhibitors of PKC such as H-7 or 
staurosporine. This issue could also be approached by 
examining the effect of these agents after long-term 
treatment of hepatocytes with phorbol esters to  down- 
regulate PKC activity. Pertinent to this issue is the 
observation that neuronal NOS contains multiple sites 
phosphorylated by protein kinases, including PKC and 
protein kinase A (3). It will also be of interest to 
determine whether substances such as angiotensin I1 
and vasopressin that activate PLC in hepatocytes also 
stimulate the inducible form of NOS. Because these 
substances also stimulate free cytosolic calcium levels, it 
will be important to evaluate the potential role of 
[Ca2 +Icyt0 as a regulator of inducible NOS activity under 
basal and stimulated conditions. 
The authors observed that concurrent treatment of 
hepatocyte cultures with phorbol esters and LPS antag- 
onized NO release. Again, it will be important to identify 
the pathway(s) that mediates this action. At least two 
isoforms of PKC have been identified in hepatocytes 
(15). Does the same isoform of PKC mediate the 
stimulatory and inhibitory actions of PKC on inducible 
NOS activity, or are distinct isoforms involved? Alter- 
natively, “cross-talk” among different second mes- 
senger systems may mediate the “dual” actions of PKC. 
For example, synergism between the a,-adrenergic 
response, glucagon and cyclic AMP and their antag- 
onism by insulin and diacylglycerol occurred in the 
modulation of cytosolic [Ca2+ I oscillations in hepato- 
cytes (14). In platelets, both NO and 8-Br-cyclic GMP 
prevented Ca2 + mobilization and platelet aggregation 
induced by receptor-mediated agonists by interfering 
with signal transduction at a point proximal to PLC 
activation (16). This suggests that NO autoregulates its 
own production by means of negative feedback on PKC 
activation. Finally, it will be important to determine 
whether these kinds of interactions occur in the time 
frame required for activation of inducible NOS in 
hepatocytes. 
From the observations of Hortelano and others, it 
appears that the liver can be induced to “say NO.” It is 
safe to say that we have not heard the last about NO as a 
potentially important regulator of hepatocyte function. 
JOHN W. WILEY, M.D. 
Department of Internal Medicine 
University of Michigan Medical Center 
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